Zefen Xiao scite author profile

After completing this course, the reader will be able to:1. Describe the present clinical practice and controversies regarding the use of PORT in resected pIIIA-pN2 NSCLC.2. Evaluate the effect of PORT on overall survival and on tumor control in this subgroup of patients.This article is available for continuing medical education credit at CME.TheOncologist.com. CME CME ABSTRACTBackground. For patients with resected pathological stage IIIA-N2 non-small cell lung cancer (NSCLC), the role of postoperative radiotherapy (PORT) is not well defined. In this single-institutional study, we re-evaluated the effect of PORT on overall survival (OS) as well as tumor control in this subgroup of patients.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Zefen Xiao

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients

Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: Report of 549 cases

Primary Small Cell Carcinoma of the Esophagus

Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution

Contact Info

Product

Resources

About